ArticlePharmacoEconomics - open2021

Economic Evaluation of First-Line Pertuzumab Therapy in Patients with HER2-Positive Metastatic Breast Cancer in Japan.

Kensuke Moriwaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.